Axolabs GmbH

General information

Axolabs GmbH
Fritz-Hornschuch-Straße 9
95326 Kulmbach, Bavaria
Germany

Contact person: Ingo Röhl, Managing Director Operations
Company main phone: +49 (9221) 827620
Company main fax: +49 (9221) 8276299
Website: https://www.axolabs.com

Year founded:	2011
Source of foundation:	Management buy-out (MBO)
Name of foundation source:	Roche Kulmbach GmbH

Corporate description / mission:
Axolabs is a custom research organization providing high-end solutions and consultancy in the field of oligonucleotide therapeutics and nucleic acid medicines. The services are tailored to specific client's needs ranging from oligonucleotide drug discovery through preclinical R&D, including Oligonucleotide Manufacturing, Analytics, Bioanalytics, Pharmacology, Consultancy etc.

State of ownership: Subsidiary
Headquarters: HQ: No

Remarks on ownership / listings
Axolabs was acquired by LGC in March 2017.

Categorization

Sector:

Biotechnology - R&D Services

Subsector:

Analytical services
Bioinformatics
CRO (Contract Research Organization)
Synthesis services

Business model:

R&D
Research on contract basis
Service company
Subsidiary

Customer segments:

Large biotech & big pharma
Small biotech

Distribution:

Direct (own sales force)

Summary Products / Services / Technologies

Description of products:
Oligonucleotide manufacturing
Oligonucleotide and nucleic acid analytics
Bioanalytics of oligonucleotides and mRNA (GLP/GCP)
Biologal services for oligonucleotide therapeutics

Special IP situation:
The intellectual property portfolio of Axolabs comprises Proprietary lipid platform for the functional delivery of oligonucleotides and mRNA, Bioanalytical methods for the detection of oligonucleotides from biological matrices and Simultaneous detection of oligonucleotides.